By Jon "DRJ" Najarian, co-founder of OptionMonster.NEW YORK -- Shares of Ziopharm Oncology (ZIOP) gapped higher this week, and option traders are betting on larger gains ahead.
Ziopharm Bulls Bet on Explosive Move
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts